Cannabix Technologies Inc. has officially entered its commercial phase with the launch of its proprietary Marijuana Breath Test (MBT) system. The company announced the commencement of the first phase of its rollout, delivering MBT units to select commercial customers across multiple industrial sectors. This milestone marks a significant transition for the firm from research and development to a revenue-generating business model. The MBT system is designed to provide rapid detection of marijuana use, addressing a growing demand for workplace safety and industrial compliance. Following the successful completion of this initial distribution phase, Cannabix plans to scale up production to meet broader market demand. Investors view this move as a positive catalyst for the company's growth trajectory and market positioning.
Sign up free to access this content
Create Free Account